UTAH MEDICAL PRODUCTS INC
For the period ended Dec 31, 2024. Filed Mar 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned this 26th day of March 2025.
UTAH MEDICAL PRODUCTS, INC.
| By: | /s/ Kevin L. Cornwell | |
| Kevin L. Cornwell | ||
| Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on this 26th day of March 2025.
| By: /s/ James H. Beeson | |
| James H. Beeson, Director | |
| By: /s/ Kevin L. Cornwell | |
| Kevin L. Cornwell, Director | |
| By: /s/ Ernst G. Hoyer | |
| Ernst G. Hoyer, Director | |
| By: /s/ Barbara A. Payne | |
| Barbara A. Payne, Director | |
| By: /s/ Paul O. Richins | |
| Paul O. Richins, Director | |
| By: /s/ Carrie Leigh | |
| Carrie Leigh, Director |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.